Article info
PDFCorrespondence
Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV risk
- Correspondence to Dr Anil Pareek, Medical Affairs and Clinical Research , Ipca Laboratories Ltd, Mumbai-400067, Maharashtra, India; anil.pareek{at}ipca.com
Citation
Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV risk
Publication history
- Received October 5, 2017
- Accepted October 7, 2017
- First published October 13, 2017.
Online issue publication
July 12, 2020
Article Versions
- Previous version (12 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.